Similarly, the presence of anti-SSB antibodies showed a significant association with mortality in pSS-ILD, with an HR of 0.42 (95% CI 0.18–0.98, P = 0.04) and low heterogeneity (I2 < 50%) (Fig. 3c). This evidence concerns the gene SSB and interstitial lung disease.